InnoMedica's main focus in drug development is on efficient drug logistics in the human body. Many fundamentally effective drugs reach the desired location in the body only in small quantities. In addition, new challenges are emerging in the treatment of diseases due to the systemic response throughout the body. InnoMedica has set itself the goal of overcoming these with its nanotechnology.

Building on 30+ years of research experience of Dr. Noboru Yamazaki, a member of InnoMedica's Board of Directors and founder of Yamazaki-DDS Co, Ltd, which was acquired by InnoMedica, InnoMedica has recognized the importance of the platform character of liposomal nanotechnology. A wide variety of applications for this nanotechnology platform are developed through a systematic approach.

InnoMedica's transport system is based on particularly small and uniform liposomes with an intelligent surface structure. These nanocarriers make medical use of the body's natural logistics for the distribution of molecules in the body. For this purpose, InnoMedica's nanocarriers are constructed from originally natural building blocks (lipids) and are modeled on the body's natural transport systems in terms of size and structure. However, the payload of the nanocarrier is a therapeutic agent.

Several elements play a key role in the establishment of the nanotechnology platform. The manufacturing process had to be changed to an innovative method with more flexible production options. The composition of the lipid coat must be adaptable depending on the medical application, and the surface of the nanocarrier must be constructed differently depending on the target tissue in the body. In addition to the desired flexibility of the nanocarrier, which opens up the potential for the technology to be adapted to a wide range of applications, stability and replicability are of key importance in the design of the prototype for individual application. In addition, the properties of the active ingredient must also be considered in combination with the design of the nanocarrier to allow for sufficient loading.

InnoMedica attributes key importance to liposomal formulations for the transport of active ingredients in the human body. Nanotechnology allows the packaging of active ingredients which are known to have potential but cannot reach the target in sufficient quantities or cause severe side effects when applied systemically without this transport system. InnoMedica aims to reduce these side effects due to the liposomal packaging of the active ingredient.

Other Topics


A key factor in InnoMedica's innovative strength is the direct link between development and pharmaceutical production.


Thanks to the multi-purpose design of InnoMedica's cleanrooms, they can be flexibly used for the production of different drugs in a modular way.